Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

277
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
277

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disturbed metabolic adaptation drives natural killer cell dysfunction in association with nosocomial infection during human sepsis.

EBioMedicine·2026
Same author

Improving bedside airway tests accuracy for predicting difficult laryngoscopy using ultrasound-measured skin-to-epiglottis distance.

Journal of anesthesia, analgesia and critical care·2026
Same author

Natural killer cell immunotherapy reverses lung fibrosis by eliminating senescent fibroblasts.

Science translational medicine·2026
Same author

Norepinephrine in Major Abdominal Surgery: Comment.

Anesthesiology·2026
Same author

Prevalence and risk factors associated with asymptomatic bacteriuria in diabetic postmenopausal women in Tripoli, Libya.

BMC infectious diseases·2026
Same author

APNEIC-M score: a simplified screening tool for difficult airway in patients with obesity.

Journal of anesthesia·2026

Related Experiment Video

Updated: Jun 16, 2026

Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells
10:44

Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells

Published on: February 3, 2011

Adoptive NK cell therapy in AML: progress and challenges.

Mona Rady1,2, Maha Mostafa3, Gabriel Dida4,5

  • 1Microbiology, Immunology and Biotechnology Department, Faculty of Pharmacy and Biotechnology, German University in Cairo (GUC), New Cairo, Egypt. mona.rady@guc.edu.eg.

Clinical and Experimental Medicine
|January 17, 2025
PubMed
Summary
This summary is machine-generated.

Natural killer (NK) cell adoptive cell therapy (ACT) shows promise for acute myeloid leukemia (AML), offering alternatives to chemotherapy. While generally safe, challenges like limited persistence and patient response variability require further research for optimal efficacy.

Keywords:
Acute myeloid leukemia (AML)Adoptive cell therapy (ACT)Graft versus host disease (GVHD)Graft versus leukemia (GVL)Hematopoietic stem cell transplantation (HSCT)NK cells

More Related Videos

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Related Experiment Videos

Last Updated: Jun 16, 2026

Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells
10:44

Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells

Published on: February 3, 2011

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Area of Science:

  • Immunology and Hematology
  • Cellular Therapy

Background:

  • Adoptive cell therapy (ACT) using natural killer (NK) cells is a developing strategy for acute myeloid leukemia (AML).
  • NK cell ACT aims to overcome chemotherapy resistance and high AML relapse rates.
  • Various NK cell sources are explored, including cell lines, CAR-NK cells, and cells from peripheral blood and umbilical cord blood.

Purpose of the Study:

  • To comprehensively analyze clinical outcomes and toxicity profiles of NK cell-based ACT for AML over the past 15 years.
  • To evaluate the efficacy, safety, and applicability of NK cells in AML treatment.
  • To identify persistent challenges and areas for improvement in NK cell therapy for AML.

Main Methods:

  • Review of clinical trials, clinical studies, and case reports concerning NK cell ACT for AML.
  • Analysis focused on therapeutic efficacy, including anti-leukemia activity and remission rates.
  • Assessment of safety profiles, specifically noting the incidence of cytokine release syndrome (CRS) and graft-versus-host disease (GVHD).

Main Results:

  • NK cell therapies demonstrate varying efficacy, from transient effects to sustained remissions in some AML patients.
  • Generally favorable safety outcomes observed, with low rates of severe adverse events like CRS and GVHD.
  • Key challenges identified include limited NK cell persistence, disease relapse, and inconsistent patient responses.

Conclusions:

  • NK cell-based adoptive cell therapy holds significant potential for treating AML.
  • Further research is crucial to address technical and biological hurdles to enhance efficacy and safety.
  • Optimizing NK cell persistence and response heterogeneity are key areas for future development.